UCB SA/NV has announced the receipt of a transparency notification from FMR LLC, headquartered in Wilmington, Delaware. The notification was received on June 12, 2025, and is pursuant to Article 14 of the law of May 2, 2007, concerning the disclosure of large shareholdings.
FMR LLC reported that following a disposal of UCB shares with voting rights by its affiliates, its shareholding in UCB SA decreased below the 7.5% threshold as of June 6, 2025. On this date, FMR LLC held 13,802,069 UCB shares with voting rights, equating to 7.10% of the total issued shares by the company (194,505,658), down from a previous holding of 7.52% (14,617,221 UCB shares) noted on April 19, 2024.
The notification reason was identified as an acquisition or disposal of voting securities or voting rights by a parent undertaking or controlling person. The threshold crossed was set at 7.5%, with a denominator of 194,505,658.
The chain of controlled undertakings includes FIAM LLC and Fidelity Institutional Asset Management Trust Company under FIAM Holdings LLC; FMR Investment Management (UK) Limited under Fidelity Management & Research Company LLC; Strategic Advisers LLC under Fidelity Advisory Holdings LLC; and Fidelity Management Trust Company under FMTC Holdings LLC. All these entities are controlled by FMR LLC.
The holdings attributed to these entities arise from various undertakings for collective investment managed by subsidiaries controlled by FMR LLC. These discretionary investment managers exercise voting rights at their discretion unless specific instructions are provided.
For more details and updates on large shareholdings in UCB SA/NV, stakeholders can visit UCB’s website.
Contact information for further inquiries is available through Investor Relations representative Antje Witte and Corporate Communications contact Laurent Schots.
UCB is a global biopharmaceutical company based in Brussels focused on developing innovative medicines for severe diseases affecting the immune system or central nervous system. The company operates in approximately 40 countries with over 9,000 employees and generated €6.1 billion in revenue in 2024.
